Published in Nature on February 05, 1971
Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. Clin Exp Immunol (1973) 2.21
Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest (1989) 2.04
Distribution of virus antibody activity among human IgG subclasses. Clin Exp Immunol (1981) 2.00
Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect Immun (1994) 1.26
Localization of the IgG effector site for monocyte receptors. Proc Natl Acad Sci U S A (1975) 1.06
Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin Exp Immunol (2001) 1.02
Human monocyte binding of homologous monomer and complexed IgG. Immunology (1982) 1.01
PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin Exp Immunol (2000) 0.99
Lack of IgA subclass restriction in antibody response to phosphorylcholine, beta lactoglobulin and tetanus toxoid. Immunology (1984) 0.98
Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages. Immunology (1987) 0.95
Investigation of the binding site of mouse IgG subclasses to homologous peritoneal macrophages. Immunology (1975) 0.94
Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. J Exp Med (1994) 0.93
Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes. Immunology (1981) 0.92
Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. J Clin Invest (1982) 0.92
Dependence of phagocytosis on strength of phagocyte-particle interaction. Immunology (1978) 0.83
The role of shed Fc receptor in the regulation of lymphocyte response to phytohaemagglutinin (PHA). Immunology (1985) 0.82
Effects of cholera exotoxin on Fc receptor activity of lymphoid cells and mononuclear phagocytes. Immunology (1977) 0.78
Monocytes/macrophages in diagnosis and immunopathogenesis. Clin Diagn Lab Immunol (1999) 0.75
Tissue-specific autoantibodies in haemolytic anaemia. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.75
Immunoglobulin profiles provide new insights into infectious diseases. Yale J Biol Med (1983) 0.75
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol (1970) 4.09
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary. Science (2002) 3.69
The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
Yersinia enterocolitica and white cell filtration. Transfusion (1992) 3.39
Localization of A antigen sites on human erythrocyte ghosts. Nature (1971) 2.99
Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94
Purification of human monocytes on microexudate-coated surfaces. J Immunol (1978) 2.86
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem (1988) 2.74
Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood (1968) 2.73
Taxonomic relations between archaebacteria including 6 novel genera examined by cross hybridization of DNAs and 16S rRNAs. J Mol Evol (1982) 2.64
Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med (1966) 2.63
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med (1966) 2.27
Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25
Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods (1986) 2.16
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
Ferroglobus placidus gen. nov., sp. nov., A novel hyperthermophilic archaeum that oxidizes Fe2+ at neutral pH under anoxic conditions. Arch Microbiol (1996) 2.06
Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood (1992) 2.05
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Operation for N2 small cell lung carcinoma. Ann Thorac Surg (1990) 2.04
Mechanochemical properties of brain clathrin: interactions with actin and alpha-actinin and polymerization into basketlike structures or filaments. Proc Natl Acad Sci U S A (1979) 2.04
Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol (1967) 2.03
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Presence of acetyl coenzyme A (CoA) carboxylase and propionyl-CoA carboxylase in autotrophic Crenarchaeota and indication for operation of a 3-hydroxypropionate cycle in autotrophic carbon fixation. J Bacteriol (1999) 1.86
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82
Myasthenia gravis. Lancet (1966) 1.82
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol (1969) 1.73
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
Respiration of arsenate and selenate by hyperthermophilic archaea. Syst Appl Microbiol (2000) 1.70
Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest (1994) 1.70
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Reclassification of the crenarchael orders and families in accordance with 16S rRNA sequence data. Int J Syst Bacteriol (1997) 1.63
A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene (2006) 1.62
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr (1982) 1.60
Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol (1972) 1.59
A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax. J Exp Med (1987) 1.58
Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr (1988) 1.57
Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology (1979) 1.55
Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant Rev (1972) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Human lymphocytes express substance P and its receptor. J Neuroimmunol (1998) 1.52
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
Organic solutes in hyperthermophilic archaea. Appl Environ Microbiol (1997) 1.49
PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene (2006) 1.48
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Human lymphocyte growth in vitro: morphologic, biochemical, and immunologic significance. Int Rev Exp Pathol (1971) 1.45
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Towards the ecology of hyperthermophiles: biotopes, new isolation strategies and novel metabolic properties. FEMS Microbiol Rev (2000) 1.42
Nitric oxide induces apoptosis in mouse thymocytes. J Immunol (1995) 1.40
Detection of flexor tenosynovitis by magnetic resonance imaging: its relationship to diurnal variation of symptoms. J Rheumatol (1991) 1.40
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
Anti-f and the "New" Rh Antigen it Defines. Proc Natl Acad Sci U S A (1953) 1.38
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A (2001) 1.36
Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol (1992) 1.36
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
Blood transfusion in liver transplantation. Transfusion (1985) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Thiobacillus ferrooxidans, a facultative hydrogen oxidizer. Appl Environ Microbiol (1990) 1.30
The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol (2012) 1.29
Development of the premature infant's host defense system and its relationship to routine immunizations. Clin Perinatol (1984) 1.27
Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. J Immunol Methods (1990) 1.27
Structure of the carbohydrate units of IgE immunoglobulin. II. Sequence of the sialic acid-containing glycopeptides. J Biol Chem (1974) 1.27
Nylon fiber leukapheresis: associated complement component changes and cranulocytopenia. Blood (1978) 1.26
Dynamics of the macrophage plasma membrane. Annu Rev Microbiol (1979) 1.26
Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun (1985) 1.26
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol (1999) 1.24
Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med (1968) 1.24
Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23
Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol (1994) 1.23
T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. Blood (1979) 1.22
Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis (1990) 1.21
ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene (2008) 1.21
In vivo observation of cell division of anaerobic hyperthermophiles by using a high-intensity dark-field microscope. J Bacteriol (1999) 1.20
Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood (1998) 1.20